Comparison

Ziconotide vs Thymosin Beta-4

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

Ziconotide

Also: Prialt, SNX-111

FDA Approved

A synthetic cone snail venom peptide for severe chronic pain. The first intrathecal non-opioid analgesic FDA approved.

HealingFDA Approved
Thymosin Beta-4

Also: TB-4, Tβ4

Clinical Trials

The full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.

HealingHuman Trials

Key Comparison Insights

  • Ziconotide is FDA approved, while Thymosin Beta-4 remains in research stages.
  • Both peptides belong to the Healing category, suggesting similar primary applications.
  • Ziconotide has stronger research evidence (FDA Approved) compared to Thymosin Beta-4 (Human Trials).

Detailed Comparison

AttributeZiconotideThymosin Beta-4
CategoryHealingHealing
FDA StatusFDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionZiconotide blocks N-type voltage-gated calcium channels (Cav2.2) in the spinal cord. This prevents neurotransmitter release from pain-signaling neurons, providing analgesia without opioid receptor involvement.Thymosin Beta-4 is the primary actin-sequestering protein in mammalian cells. It regulates actin polymerization, promotes cell migration, angiogenesis, and wound healing. TB-4 also has anti-inflammatory properties and promotes stem cell differentiation. The active healing region of TB-4 was isolated to create the synthetic fragment TB-500.
Common Dosing
Limited community data available
See research protocols
2.5-5 mg 2-3x weekly
2-3x weekly
AdministrationIntrathecal infusion onlySubcutaneous injection, topical for eye conditions
Typical DurationChronic use via intrathecal pump4-8 weeks typical protocol
Best Time to TakeMorning or as directedMorning or split doses
Possible Side Effects
May vary by individual
  • Dizziness (40%)
  • Nausea
  • Confusion
  • Hallucinations
  • Depression
  • +4 more
  • Generally well-tolerated
  • Injection site reactions
  • Headache
  • Fatigue
  • May trigger histamine release - use caution with MCAS or histamine sensitivity
  • +3 more
Research SummaryEffective for severe chronic pain refractory to other treatments. Studies show significant pain reduction without tolerance development. Complex delivery limits use to specialized pain centers.Extensive research on wound healing, cardiac repair, and tissue regeneration. Studies show TB-4 accelerates dermal wound closure and promotes corneal epithelial healing. Research in cardiac repair shows improved outcomes post-myocardial infarction in animal models. The shorter half-life means more frequent dosing compared to TB-500.

Frequently Asked Questions: Ziconotide vs Thymosin Beta-4

What is the difference between Ziconotide and Thymosin Beta-4?

Ziconotide is a healing peptide that a synthetic cone snail venom peptide for severe chronic pain. the first intrathecal non-opioid analgesic fda approved. Thymosin Beta-4 is a healing peptide that the full 43-amino acid protein that tb-500 is derived from. naturally occurring in most human tissues, tb-4 has a shorter half-life (~2 hours) compared to its synthetic fragment tb-500 (~2-4 days). often mislabeled as 'tb-500' by vendors in premixed products. The main differences lie in their mechanisms of action and clinical applications.

Which is better, Ziconotide or Thymosin Beta-4?

Neither is universally "better" - the choice depends on your specific goals. Ziconotide is typically used for healing purposes, while Thymosin Beta-4 is used for healing. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can Ziconotide and Thymosin Beta-4 be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using Ziconotide and Thymosin Beta-4 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of Ziconotide and Thymosin Beta-4 is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.